Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16411313 | 0.78 | ALDH1A1 (0.37) | TSHRGLAHTTL3MBTL1ALDH1A1 | |
| SCHEMBL16683752 | 0.77 | ALDH1A1 (0.40) | TSHRGLAHTTL3MBTL1ALDH1A1 | |
| SCHEMBL16439971 | 0.77 | ALDH1A1 (0.36) | TSHRGLAHTTL3MBTL1ALDH1A1 | |
| SCHEMBL28756467 | 0.77 | ALDH1A1 (0.36) | TSHRGLAHTTL3MBTL1ALDH1A1 | |
| SCHEMBL725427 | 0.76 | TSHR (0.35) | TSHRGLAHTTL3MBTL1ALDH1A1 | |
| SCHEMBL820218 | 0.73 | TSHR (0.36) | TSHRGLAHTTL3MBTL1ALDH1A1 | |
| SCHEMBL23057961 | 0.73 | CA2 (0.38) | — | |
| SCHEMBL19799279 | 0.73 | LMNA (0.35) | TSHRGLAHTTL3MBTL1ALDH1A1 | |
| SCHEMBL15672890 | 0.72 | TSHR (0.33) | TSHRGLAHTTL3MBTL1ALDH1A1 | |
| SCHEMBL29834913 | 0.72 | TSHR (0.49) | TSHRALDH1A1TDP1CYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8673183-B2 | Tetrazine monomers and copolymers for use in organic electronic devices | NATIONAL RESEARCH COUNCIL OF CANADA | 2014-03-18 | — | — | US | disclosed |
| US-20120007026-A1 | TETRAZINE MONOMERS AND COPOLYMERS FOR USE IN ORGANIC ELECTRONIC DEVICES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120007026-A1 | TETRAZINE MONOMERS AND COPOLYMERS FOR USE IN ORGANIC ELECTRONIC DEVICES | CCNE1, CCNE2, WEE1 | TSHR 2462/4885GLA 4789/4885HTT 2605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.